Stock Analiz

Inovio Pharmaceuticals, Inc. (INO) stock forecast and price target

Price $1.43 · data as of November 13, 2026

12-month price target

Average target$6.33
Upside / downside+342.9%
Analysts3
ConsensusStrong buy
Low $5.00Average $6.33High $8.00

Gold marker: average target · white marker: today’s price ($1.43)

Analyst ratings

Strong buy 1Buy 2Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.90—$349330
Next fiscal year
ends December 31, 2027
$-0.35—$43M
Quarter after
ends December 31, 2026
$-0.10—$6M

Consensus of the analysts covering Inovio Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.

Frequently asked questions

What is the Inovio Pharmaceuticals stock price target?

The average 12-month target from 3 analysts is $6.33, 342.9% above the current price of $1.43 Targets range from $5.00 to $8.00.

Is Inovio Pharmaceuticals a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 2 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Inovio Pharmaceuticals expected to earn?

Analysts expect EPS of $-0.90 for the fiscal year ending December 31, 2026 and $-0.35 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.